Investing.com - Clorox (NYSE: CLX) reported third quarter EPS of $1.71, $0.35 better than the analyst estimate of $1.36. Revenue for the quarter came in at $181B versus the consensus estimate of $1.87B.
Guidance
Clorox sees FY 2024 EPS of $5.80-$5.95 versus the analyst consensus of $5.58.
Clorox's stock price closed at $147.81. It is down -5.47% in the last 3 months and down -11.55% in the last 12 months.
Clorox saw 3 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Clorox's stock price’s past reactions to earnings here.
According to InvestingPro, Clorox's Financial Health score is "fair performance".
Check out Clorox's recent earnings performance, and Clorox's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar